| 000 | 01448 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516025735.0 | ||
| 264 | 0 | _c20120125 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1600-0897 | ||
| 024 | 7 |
_a10.1111/j.1600-0897.2011.00988.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoni, Simmi | |
| 245 | 0 | 0 |
_aPrognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles. _h[electronic resource] |
| 260 |
_bAmerican journal of reproductive immunology (New York, N.Y. : 1989) _cSep 2011 |
||
| 300 |
_a230-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChorionic Gonadotropin, beta Subunit, Human _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aFas Ligand Protein _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGestational Trophoblastic Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydatidiform Mole _xblood |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_afas Receptor _xblood |
| 700 | 1 | _aRath, Gayatri | |
| 700 | 1 | _aDeval, Ravi | |
| 700 | 1 | _aSalhan, Sudha | |
| 700 | 1 | _aMishra, Ashwini Kumar | |
| 700 | 1 | _aSaxena, Sunita | |
| 773 | 0 |
_tAmerican journal of reproductive immunology (New York, N.Y. : 1989) _gvol. 66 _gno. 3 _gp. 230-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0897.2011.00988.x _zAvailable from publisher's website |
| 999 |
_c20657756 _d20657756 |
||